42 subscribers
Treceți offline cu aplicația Player FM !
Biotech Story Time With Tal Zaks, M.D. (Part 1)
Manage episode 457125711 series 2739469
We love to hear from our listeners. Send us a message.
Tal Zaks, M.D. was Chief Medical Officer at Moderna before, during, and immediately following the company's headline role during the COVID pandemic. If that doesn't pique your interest about the stories he can tell, this episode of the Business of Biotech surely will. Tal is now leading a new mRNA-centric startup called Exsilio Therapeutics, which Advancing RNA's Anna Rose Welch and I dig into in part two of our talk with Tal, slated for release in early January. Yep, Story Time With Tal is so good, we doubled up the episodes with him. Tune in for insight from the early days of mRNA that you probably haven't heard before, and stay for a glimpse of its future role in therapeutics at Exsilio with one of the foremost thinkers in the space.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
Capitole
1. Biotech Story Time With Tal Zaks, M.D. (Part 1) (00:00:00)
2. Tales of a Biotech Builder (00:00:04)
3. From Oncology to Biotech Innovation (00:09:27)
4. Building Public Trust in Biotech (00:16:24)
5. Navigating the mRNA Vaccine Landscape (00:29:16)
6. Journey to Biotech Leadership (00:35:18)
7. Innovation and Return on Investment (00:40:35)
8. Exploring Innovations in mRNA Therapies (00:45:33)
238 episoade
Manage episode 457125711 series 2739469
We love to hear from our listeners. Send us a message.
Tal Zaks, M.D. was Chief Medical Officer at Moderna before, during, and immediately following the company's headline role during the COVID pandemic. If that doesn't pique your interest about the stories he can tell, this episode of the Business of Biotech surely will. Tal is now leading a new mRNA-centric startup called Exsilio Therapeutics, which Advancing RNA's Anna Rose Welch and I dig into in part two of our talk with Tal, slated for release in early January. Yep, Story Time With Tal is so good, we doubled up the episodes with him. Tune in for insight from the early days of mRNA that you probably haven't heard before, and stay for a glimpse of its future role in therapeutics at Exsilio with one of the foremost thinkers in the space.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
Capitole
1. Biotech Story Time With Tal Zaks, M.D. (Part 1) (00:00:00)
2. Tales of a Biotech Builder (00:00:04)
3. From Oncology to Biotech Innovation (00:09:27)
4. Building Public Trust in Biotech (00:16:24)
5. Navigating the mRNA Vaccine Landscape (00:29:16)
6. Journey to Biotech Leadership (00:35:18)
7. Innovation and Return on Investment (00:40:35)
8. Exploring Innovations in mRNA Therapies (00:45:33)
238 episoade
Toate episoadele
×1 High-Throughput Discovery With Bioptic's Andrey Dobry 1:13:36
1 RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D. 1:06:32
1 Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal) 54:04
1 Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D. 1:02:34
1 Biotech Story Time With Tal Zaks, M.D. (Part 1) 55:25
1 A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D. 52:50
1 Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski 1:03:50
1 Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D. 45:26
1 T-Cells For The Win With Adaptimmune's Adrian Rawcliffe 1:01:35
1 Serving The Underserved With Gates MRI's Claire Wagner, M.D. 46:48
1 An Unanticipated Biotech Startup With OS Therapies' Paul Romness 49:12
1 Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright 44:14
1 Obesity Tx End-Around With Skye Bioscience's Punit Dhillon 1:02:41
1 Biotech C-Suite Construction With Allan Shaw 51:34
Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.